高级检索
当前位置: 首页 > 详情页

重楼皂苷ⅰ调控sp1/mir-542-3p/ilk信号通路对肺癌细胞的抑制作用

Inhibiting effect of Polyphyllin I on the cell growth of lung cancer by regulating Sp1/miR-542-3p/ILK signaling pathway

| 认领 | 导出 |

文献详情

资源类型:

收录情况: ◇ 统计源期刊 ◇ 北大核心 ◇ CSCD-C ◇ 卓越:梯队期刊

机构: [1]Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, China [2]Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou 510120, China [3]State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine,Guangzhou 510120, China
出处:
ISSN:

关键词: Polyphyllin Ⅰ (PPⅠ) Lung cancer MiR-542-3p Sp1 ILK Anticancer molecular mechanism

摘要:
Abstract: Objective: To investigate the effect of Chinese herbal medicine Polyphyllin Ⅰ (PPⅠ) on the cell growth inhibition of lung cancer and its molecular mechanisms. Methods: MTT, Wound healing assay and cell cycle assay were performed to detect the effects of PPⅠ on the cell growth, migration and cell cycle of lung cancer. Western Blot analysis was used to determine the protein expression of transcriptional regulator Sp1 and integrin-linked kinase ILK. qPCR analysis was used to detect the expression of miR-542-3p and ILK mRNA. Overexpression plasmids or siRNAs of ILK and Sp1 were transfected by using cell transient transfection technique. Dual-luciferase reporter assay was performed to measure the ILK promoter activity. Results: The results showed that PPⅠ significantly inhibited the cell viability of A549 and PC9 cells in a time and dose dependent manner. Western Blot results confirmed that PPⅠ down-regulated the expression of ILK protein. Silencing of ILK inhibited cell viability and migration, and arrested the cell cycle in S phase. Conversely, overexpression of ILK promoted the cell viability and reversed the growth inhibitory effect of PPⅠ on A549 and PC9 cells. miR-542-3p significantly suppressed the expression of ILK protein through directly binding to the 3’-UTR of ILK mRNA. PPⅠ could effectively increase miR-542-3p expression a t the same time. On the other hand, the protein expression of Sp1, a transcription regulated factor bound to ILK promoter region, was significantly down-regulated by PPⅠ. Silencing of Sp1 inactivated the ILK promoter activity and decreased the expression of ILK protein. Overexpression of Sp1 effectively reversed the effect of PPI-reduced expression of ILK protein. Conclusion: PPⅠ significantly inhibited the cell growth of lung cancer by decreasing the ILK protein expression through increasing the level of miR- 542-3p and down-regulation of Sp1.

基金:
语种:
第一作者:
第一作者机构: [1]Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, China [2]Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou 510120, China
通讯作者:
通讯机构: [2]Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou 510120, China [3]State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine,Guangzhou 510120, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号